A cost-consequence analysis of pertuzumab in the neoadjuvant treatment of high-risk HER2+Early-Stage Breast Cancer (EBC): health-economic considerations for drug availability in Italy
CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要